tert-Butyl N-(4-amino-3-hydroxyphenyl)carbamate

Catalog No.: 
ACRAJZ473
CAS No.: 
1700236-34-5
Molecular Formula: 
C11H16N2O3
Molecular Weight: 
224.26
tert-Butyl N-(4-amino-3-hydroxyphenyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$231.00In stockInquiry
250mg95%$390.00In stockInquiry
1g95%$1053.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl N-(4-amino-3-hydroxyphenyl)carbamate
IUPAC Nametert-butyl (4-amino-3-hydroxyphenyl)carbamate
MDL No.MFCD31873070
Molecular FormulaC11H16N2O3
Molecular Weight224.26
SMILESO=C(OC(C)(C)C)NC1=CC=C(N)C(O)=C1
InChI KeyLTKMKDXROAXPJF-UHFFFAOYSA-N
SynonymCarbamic acid, N-(4-amino-3-hydroxyphenyl)-, 1,1-dimethylethyl ester;tert-Butyl N-(4-amino-3-hydroxyphenyl)carbamate
CAS No.1700236-34-5
PubChem CID130481146

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRAJZ473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPHZY792 route compound structure diagram
    ACPHZY79289691-80-5In Stock
  4. Then
  5. ACRAJZ473 route product structure diagram
    ACRAJZ4731700236-34-5In Stock
Inquiry

2. ACRAJZ473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRAJZ473 route product structure diagram
    ACRAJZ4731700236-34-5In Stock
Inquiry

3. ACRAJZ473 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRAJZ473 route product structure diagram
    ACRAJZ4731700236-34-5In Stock
Inquiry

Comments (0)